AHA Schedule 2014: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(32 intermediate revisions by the same user not shown)
Line 60: Line 60:


===2:00 PM===
===2:00 PM===
<font color=red>OPEN TIME SLOT</font>
''2:00 PM - 2:30 PM''
*'''Interviewee:''' Dr. Joseph Muhlestein
*'''Topic:''' Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using Coronary CT Angiography: Primary Results of FACTOR-64, a Randomized Controlled Trial   
*'''Embargo Lift:''' Monday, November 17, 2014 at 11:07 AM


===2:30 PM===
===2:30 PM===
Line 83: Line 86:
<font color=red>OPEN TIME SLOT</font>
<font color=red>OPEN TIME SLOT</font>


===8:30 AM===
===8:45 AM===
<font color=red>OPEN TIME SLOT</font>
''8:45 AM - 9:00 AM''
*'''Interviewee:''' Dr. Stefanie Schulz
*'''Topic:''' Randomized, Double Blind Trial of 6 Versus 12 Months Of Dual Antiplatelet Therapy After DES-Implantation (ISAR-SAFE)
*'''Embargo Lift:''' Sunday, November 16, 2014 at 3:55 PM


===9:00 AM===
===9:00 AM===
<font color=red>OPEN TIME SLOT</font>
''9:00 AM - 9:30 AM''
*'''Interviewee:''' Dr. Kirk N. Garratt 
*'''Topic:''' Increased Risk of Ischemic Events Upon Discontinuation of Prasugrel After 12 or 30 Months of Therapy Following Placement of the Taxus Liberté Paclitaxel- Eluting Coronary Stent     
*'''Embargo Lift:''' Sunday, November 16, 2014 at 4:05 PM       


===9:30 AM===
===9:30 AM===
<font color=red>OPEN TIME SLOT</font>
''9:30 AM - 10:00 AM''
*'''Interviewee:''' Dr. Martine Gilard
*'''Topic:''' Is 6 Months DAPT Post Coronary Stenting Non Inferior To 24 Months? The Italic/ Italic+ Randomized Trial. Results of the One Year Primary Endpoint
*'''Embargo Lift:''' Sunday, November 16, 2014 at 4:05 PM       


===10:00 AM===
===10:00 AM===
Line 99: Line 111:


===11:00 AM===
===11:00 AM===
<font color=red>OPEN TIME SLOT</font>
===11:30 AM===
<font color=red>OPEN TIME SLOT</font>
===12:00 PM===
<font color=red>OPEN TIME SLOT</font>
===12:30 PM===
<font color=red>OPEN TIME SLOT</font>
===1:00 PM===
<font color=red>OPEN TIME SLOT</font>
===1:30 PM===
<font color=red>OPEN TIME SLOT</font>
===2:00 PM===
<font color=red>OPEN TIME SLOT</font>
<font color=red>OPEN TIME SLOT</font>


Line 133: Line 127:
===4:30 PM===
===4:30 PM===
<font color=red>OPEN TIME SLOT</font>
<font color=red>OPEN TIME SLOT</font>


==Monday, November 17, 2014==
==Monday, November 17, 2014==


===8:00 AM===
===8:00 AM===
<font color=red>OPEN TIME SLOT</font>
''8:00 AM - 8:30 AM''
*'''Interviewee:''' Dr. Christopher Granger and Dr. James Jollis     
*'''Topic:''' Developing Regional STEMI Systems of Care: Final Results of the Mission: Lifeline STEMI ACCELERATOR Study         
*'''Embargo Lift:''' Wednesday, November 19, 2014 at 11:41 AM       


===8:30 AM===
===8:30 AM===
<font color=red>OPEN TIME SLOT</font>
''8:30 AM - 9:00 AM''
*'''Interviewee:''' Dr. Christoph Kaiser
*'''Topic:''' Long-term Outcome of Biodegradable Compared to Durable Polymer Drug-eluting Stents and Bare Metal Stents - Main Results of a Prospective Randomized Trial     
*'''Embargo Lift:''' Wednesday, November 19, 2014 at 10:45 AM     


===9:00 AM===
===9:00 AM===
<font color=red>OPEN TIME SLOT</font>
''9:00 AM - 9:15 AM''
*'''Interviewee:''' Dr. Patrick Moriarty     
*'''Topic:''' ODYSSEY ALTERNATIVE: Efficacy And Safety of the Proprotein Convertase Subtilisin/kexin Type 9 Monoclonal Antibody, Alirocumab, versus Ezetimibe, in Patients With Statin Intolerance as Defined by a Placebo Run-in and Statin Rechallenge Arm     
*'''Embargo Lift:''' Monday, November 17, 2014 at 11:29 AM     
 
===9:15 AM===
''9:15 AM - 9:30 AM''
*'''Interviewee:''' Dr. Robert Giugliano
*'''Topic:''' IMPROVE-IT Trial: A Comparison of Ezetimibe/Simvastatin versus Simvastatin Monotherapy on Cardiovascular Outcomes After Acute Coronary Syndromes
*'''Embargo Lift:''' Monday, November 17, 2014 at 11:51 AM


===9:30 AM===
===9:30 AM===
<font color=red>OPEN TIME SLOT</font>
''9:30 AM - 10:00 AM''
*'''Interviewee:''' Dr. Renato Lopes       
*'''Topic:''' AHA 2014 Wrap-Up in Portuguese


===10:00 AM===
===10:00 AM===
<font color=red>OPEN TIME SLOT</font>
<font color=red>OPEN TIME SLOT</font


===10:30 AM===
===10:30 AM===
Line 171: Line 181:


===1:30 PM===
===1:30 PM===
<font color=red>OPEN TIME SLOT</font>
''1:30 PM - 2:00 PM''
*'''Interviewee:''' Dr. Philip Aylward
*'''Topic:''' AHA 2014 Wrap-Up from a Pacific Rim perspective     


===2:00 PM===
===2:00 PM===
Line 177: Line 189:


===2:30 PM===
===2:30 PM===
<font color=red>OPEN TIME SLOT</font>
''2:30 PM - 3:00 PM''
*'''Interviewee:''' Dr. Paul Armstrong, Dr. Justin Ezekowitz, Dr. Robert Welsh and Dr. Shaun Goodman     
*'''Topic:''' AHA 2014 Wrap-Up from a Canadian perspective     


===3:00 PM===
===3:00 PM===
Line 183: Line 197:


===3:30 PM===
===3:30 PM===
<font color=red>OPEN TIME SLOT</font>
''3:30 PM - 4:00 PM''
*'''Interviewee:''' Dr. Samuel Wright
*'''Topic:''' CSL112 Posters: “CSL112 Enhances Cholesterol Efflux Equally in Patients with high and Low HDL Functionality” and “Mechanism of HDL remodeling induced by CSL112”)
*'''Embargo Lift:''' Tuesday, November 18, 2014


===4:00 PM===
===4:00 PM===
<font color=red>OPEN TIME SLOT</font>
''4:00 PM - 4:15 PM''
*'''Interviewee:''' Dr. Basil Lewis       
*'''Topic:''' AHA 2014 Wrap-Up in Hebrew
 
===4:15 PM===
''4:15 PM - 4:45 PM''
*'''Interviewee:''' Dr. Kazuyuki Shimada     
*'''Topic:''' Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Elderly Patients With Multiple Atherosclerotic Risk Factors: A Randomized Controlled Trial     
*'''Embargo Lift:''' Monday, November 17, 2014 at 10:45 AM


===4:30 PM===
===5:00 PM===
<font color=red>OPEN TIME SLOT</font>
<font color=red>OPEN TIME SLOT</font>


===5:30 PM===
''5:30 PM - 6:00 PM''
*'''Interviewee:''' Dr. Gilles Montalescot       
*'''Topic:''' AHA 2014 Wrap-Up in French


==Tuesday, November 18, 2014==
==Tuesday, November 18, 2014==
===7:30 AM===
''7:30 AM - 8:00 AM''
*'''Interviewee:''' Dr. Robert Michler       
*'''Topic:''' The Surgical Treatment of Moderate Ischemic Mitral Regurgitation: A Randomized Clinical Trial From The Cardiothoracic Surgical Trials Network
*'''Embargo Lift:''' Tuesday, November 18, 2014 at 11:51 AM


===8:00 AM===
===8:00 AM===
Line 201: Line 236:


===9:00 AM===
===9:00 AM===
<font color=red>OPEN TIME SLOT</font>
''9:00 AM - 9:30 AM''
*'''Interviewee:''' Dr. Dean Kereiakes       
*'''Topic:''' Primary Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent
*'''Embargo Lift:''' Wednesday, November 19, 2014 at 10:55 AM


===9:30 AM===
===9:30 AM===
Line 207: Line 245:


===10:00 AM===
===10:00 AM===
<font color=red>OPEN TIME SLOT</font>
''10:00 AM - 10:30 AM''
*'''Interviewee:''' Dr. Dion Stub         
*'''Topic:''' A Randomised Controlled Trial of Oxygen Therapy in Acute St-segment Elevation Myocardial Infarction: The Air Versus Oxygen in Myocardial Infarction (AVOID) Study           
*'''Embargo Lift:''' Wednesday, November 19, 2014 at 11:19 AM     


===10:30 AM===
===10:30 AM===
Line 219: Line 260:


===12:00 PM===
===12:00 PM===
<font color=red>OPEN TIME SLOT</font>
''12:00 PM - 12:30 PM''
*'''Interviewee:''' Dr. Hisao Ogawa         
*'''Topic:''' AHA 2014 Wrap-Up in Japanese


===12:30 PM===
===12:30 PM===
Line 231: Line 274:


===2:00 PM===
===2:00 PM===
<font color=red>OPEN TIME SLOT</font>
''2:00 PM - 2:30 PM''
*'''Interviewee:''' Dr. Stefan James       
*'''Topic:''' AHA 2014 Wrap-Up from a Scandinavian perspective


===2:30 PM===
===2:30 PM===
<font color=red>OPEN TIME SLOT</font>
''2:30 PM - 3:00 PM''
*'''Interviewee:''' Dr. Mark Dayer
*'''Topic:''' The Incidence of Infective Endocarditis in England is Increasing - An Assessment of the Impact of Cessation of Antibiotic Prophylaxis Using Population Statistics
*'''Embargo Lift:''' Tuesday, November 18, 2014 at 11:29 AM 


===3:00 PM===
===3:00 PM===
<font color=red>OPEN TIME SLOT</font>
''3:00 PM - 3:30 PM''
*'''Interviewee:''' Dr. Freek W.A. Verheugt         
*'''Topic:''' AHA 2014 Wrap-Up from a Netherlands perspective


===3:30 PM===
===3:30 PM===
Line 247: Line 297:
===4:30 PM===
===4:30 PM===
<font color=red>OPEN TIME SLOT</font>
<font color=red>OPEN TIME SLOT</font>


==Wednesday, November 19, 2014==
==Wednesday, November 19, 2014==
Line 264: Line 313:


===10:00 AM===
===10:00 AM===
<font color=red>OPEN TIME SLOT</font>
''10:00 AM - 10:30 AM''
*'''Interviewee:''' Dr. Anna Axelsson     
*'''Topic:''' A Randomized Trial of Losartan In Hypertrophic Cardiomyopathy - The INHERIT Trial
*'''Embargo Lift:''' Tuesday, November 18, 2014 at 11:07 AM     


===10:30 AM===
===10:30 AM===
<font color=red>OPEN TIME SLOT</font>
''10:30 AM - 11:00 AM''
*'''Interviewee:''' Dr. Laura Mauri
*'''Topic:''' Risk and Benefit of Prolonged Dual Antiplatelet Therapy After Drug-eluting Coronary Stents: Primary Endpoint Results from the Dual Antiplatelet Therapy Study     
*'''Embargo Lift:''' Sunday, November 16, 2014 at 4:15 PM     


===11:00 AM===
===11:00 AM===
<font color=red>OPEN TIME SLOT</font>
''11:00 AM - 11:30 AM''
*'''Interviewee:''' Dr. Westby Fisher   
*'''Topic:''' ABIM Maintenance of Certification program     


===11:30 AM===
===11:30 AM===
Line 297: Line 354:


===3:30 PM===
===3:30 PM===
<font color=red>OPEN TIME SLOT</font>
''3:30 PM - 4:00 PM''
*'''Interviewee:''' Prof. Dr. Sigmund Silber   
*'''Topic:''' AHA 2014 Wrap-Up in German


===4:00 PM===
===4:00 PM===

Latest revision as of 16:49, 13 November 2014

Here is the page we will use to coordinate the TV events at AHA 2014. Open time slots are indicated below in red.

Filming Location: Hyatt Regency McCormick Place, 2233 S. Martin Luther King Drive, Chicago, IL 60616



Click on Date for Detailed Schedule

Saturday, November 15, 2014

Sunday, November 16, 2014

Monday, November 17, 2014

Tuesday, November 18, 2014

Wednesday, November 19, 2014



Saturday, November 15, 2014

8:00 AM

OPEN TIME SLOT

8:30 AM

OPEN TIME SLOT

9:00 AM

OPEN TIME SLOT

9:30 AM

OPEN TIME SLOT

10:00 AM

OPEN TIME SLOT

10:30 AM

OPEN TIME SLOT

11:00 AM

OPEN TIME SLOT

11:30 AM

OPEN TIME SLOT

12:00 PM

OPEN TIME SLOT

12:30 PM

OPEN TIME SLOT

1:00 PM

OPEN TIME SLOT

1:30 PM

OPEN TIME SLOT

2:00 PM

2:00 PM - 2:30 PM

  • Interviewee: Dr. Joseph Muhlestein
  • Topic: Screening For Asymptomatic Obstructive Coronary Artery Disease Among High-Risk Diabetic Patients Using Coronary CT Angiography: Primary Results of FACTOR-64, a Randomized Controlled Trial
  • Embargo Lift: Monday, November 17, 2014 at 11:07 AM

2:30 PM

OPEN TIME SLOT

3:00 PM

OPEN TIME SLOT

3:30 PM

OPEN TIME SLOT

4:00 PM

OPEN TIME SLOT

4:30 PM

OPEN TIME SLOT


Sunday, November 16, 2014

8:00 AM

OPEN TIME SLOT

8:45 AM

8:45 AM - 9:00 AM

  • Interviewee: Dr. Stefanie Schulz
  • Topic: Randomized, Double Blind Trial of 6 Versus 12 Months Of Dual Antiplatelet Therapy After DES-Implantation (ISAR-SAFE)
  • Embargo Lift: Sunday, November 16, 2014 at 3:55 PM

9:00 AM

9:00 AM - 9:30 AM

  • Interviewee: Dr. Kirk N. Garratt
  • Topic: Increased Risk of Ischemic Events Upon Discontinuation of Prasugrel After 12 or 30 Months of Therapy Following Placement of the Taxus Liberté Paclitaxel- Eluting Coronary Stent
  • Embargo Lift: Sunday, November 16, 2014 at 4:05 PM

9:30 AM

9:30 AM - 10:00 AM

  • Interviewee: Dr. Martine Gilard
  • Topic: Is 6 Months DAPT Post Coronary Stenting Non Inferior To 24 Months? The Italic/ Italic+ Randomized Trial. Results of the One Year Primary Endpoint
  • Embargo Lift: Sunday, November 16, 2014 at 4:05 PM

10:00 AM

OPEN TIME SLOT

10:30 AM

OPEN TIME SLOT

11:00 AM

OPEN TIME SLOT

2:30 PM

OPEN TIME SLOT

3:00 PM

OPEN TIME SLOT

3:30 PM

OPEN TIME SLOT

4:00 PM

OPEN TIME SLOT

4:30 PM

OPEN TIME SLOT

Monday, November 17, 2014

8:00 AM

8:00 AM - 8:30 AM

  • Interviewee: Dr. Christopher Granger and Dr. James Jollis
  • Topic: Developing Regional STEMI Systems of Care: Final Results of the Mission: Lifeline STEMI ACCELERATOR Study
  • Embargo Lift: Wednesday, November 19, 2014 at 11:41 AM

8:30 AM

8:30 AM - 9:00 AM

  • Interviewee: Dr. Christoph Kaiser
  • Topic: Long-term Outcome of Biodegradable Compared to Durable Polymer Drug-eluting Stents and Bare Metal Stents - Main Results of a Prospective Randomized Trial
  • Embargo Lift: Wednesday, November 19, 2014 at 10:45 AM

9:00 AM

9:00 AM - 9:15 AM

  • Interviewee: Dr. Patrick Moriarty
  • Topic: ODYSSEY ALTERNATIVE: Efficacy And Safety of the Proprotein Convertase Subtilisin/kexin Type 9 Monoclonal Antibody, Alirocumab, versus Ezetimibe, in Patients With Statin Intolerance as Defined by a Placebo Run-in and Statin Rechallenge Arm
  • Embargo Lift: Monday, November 17, 2014 at 11:29 AM

9:15 AM

9:15 AM - 9:30 AM

  • Interviewee: Dr. Robert Giugliano
  • Topic: IMPROVE-IT Trial: A Comparison of Ezetimibe/Simvastatin versus Simvastatin Monotherapy on Cardiovascular Outcomes After Acute Coronary Syndromes
  • Embargo Lift: Monday, November 17, 2014 at 11:51 AM

9:30 AM

9:30 AM - 10:00 AM

  • Interviewee: Dr. Renato Lopes
  • Topic: AHA 2014 Wrap-Up in Portuguese

10:00 AM

OPEN TIME SLOT</font

10:30 AM

OPEN TIME SLOT

11:00 AM

OPEN TIME SLOT

11:30 AM

OPEN TIME SLOT

12:00 PM

OPEN TIME SLOT

12:30 PM

OPEN TIME SLOT

1:00 PM

OPEN TIME SLOT

1:30 PM

1:30 PM - 2:00 PM

  • Interviewee: Dr. Philip Aylward
  • Topic: AHA 2014 Wrap-Up from a Pacific Rim perspective

2:00 PM

OPEN TIME SLOT

2:30 PM

2:30 PM - 3:00 PM

  • Interviewee: Dr. Paul Armstrong, Dr. Justin Ezekowitz, Dr. Robert Welsh and Dr. Shaun Goodman
  • Topic: AHA 2014 Wrap-Up from a Canadian perspective

3:00 PM

OPEN TIME SLOT

3:30 PM

3:30 PM - 4:00 PM

  • Interviewee: Dr. Samuel Wright
  • Topic: CSL112 Posters: “CSL112 Enhances Cholesterol Efflux Equally in Patients with high and Low HDL Functionality” and “Mechanism of HDL remodeling induced by CSL112”)
  • Embargo Lift: Tuesday, November 18, 2014

4:00 PM

4:00 PM - 4:15 PM

  • Interviewee: Dr. Basil Lewis
  • Topic: AHA 2014 Wrap-Up in Hebrew

4:15 PM

4:15 PM - 4:45 PM

  • Interviewee: Dr. Kazuyuki Shimada
  • Topic: Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Elderly Patients With Multiple Atherosclerotic Risk Factors: A Randomized Controlled Trial
  • Embargo Lift: Monday, November 17, 2014 at 10:45 AM

5:00 PM

OPEN TIME SLOT

5:30 PM

5:30 PM - 6:00 PM

  • Interviewee: Dr. Gilles Montalescot
  • Topic: AHA 2014 Wrap-Up in French

Tuesday, November 18, 2014

7:30 AM

7:30 AM - 8:00 AM

  • Interviewee: Dr. Robert Michler
  • Topic: The Surgical Treatment of Moderate Ischemic Mitral Regurgitation: A Randomized Clinical Trial From The Cardiothoracic Surgical Trials Network
  • Embargo Lift: Tuesday, November 18, 2014 at 11:51 AM

8:00 AM

OPEN TIME SLOT

8:30 AM

OPEN TIME SLOT

9:00 AM

9:00 AM - 9:30 AM

  • Interviewee: Dr. Dean Kereiakes
  • Topic: Primary Outcomes of the EVOLVE II Trial: A Prospective Randomized Investigation of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent
  • Embargo Lift: Wednesday, November 19, 2014 at 10:55 AM

9:30 AM

OPEN TIME SLOT

10:00 AM

10:00 AM - 10:30 AM

  • Interviewee: Dr. Dion Stub
  • Topic: A Randomised Controlled Trial of Oxygen Therapy in Acute St-segment Elevation Myocardial Infarction: The Air Versus Oxygen in Myocardial Infarction (AVOID) Study
  • Embargo Lift: Wednesday, November 19, 2014 at 11:19 AM

10:30 AM

OPEN TIME SLOT

11:00 AM

OPEN TIME SLOT

11:30 AM

OPEN TIME SLOT

12:00 PM

12:00 PM - 12:30 PM

  • Interviewee: Dr. Hisao Ogawa
  • Topic: AHA 2014 Wrap-Up in Japanese

12:30 PM

OPEN TIME SLOT

1:00 PM

OPEN TIME SLOT

1:30 PM

OPEN TIME SLOT

2:00 PM

2:00 PM - 2:30 PM

  • Interviewee: Dr. Stefan James
  • Topic: AHA 2014 Wrap-Up from a Scandinavian perspective

2:30 PM

2:30 PM - 3:00 PM

  • Interviewee: Dr. Mark Dayer
  • Topic: The Incidence of Infective Endocarditis in England is Increasing - An Assessment of the Impact of Cessation of Antibiotic Prophylaxis Using Population Statistics
  • Embargo Lift: Tuesday, November 18, 2014 at 11:29 AM

3:00 PM

3:00 PM - 3:30 PM

  • Interviewee: Dr. Freek W.A. Verheugt
  • Topic: AHA 2014 Wrap-Up from a Netherlands perspective

3:30 PM

OPEN TIME SLOT

4:00 PM

OPEN TIME SLOT

4:30 PM

OPEN TIME SLOT

Wednesday, November 19, 2014

8:00 AM

OPEN TIME SLOT

8:30 AM

OPEN TIME SLOT

9:00 AM

OPEN TIME SLOT

9:30 AM

OPEN TIME SLOT

10:00 AM

10:00 AM - 10:30 AM

  • Interviewee: Dr. Anna Axelsson
  • Topic: A Randomized Trial of Losartan In Hypertrophic Cardiomyopathy - The INHERIT Trial
  • Embargo Lift: Tuesday, November 18, 2014 at 11:07 AM

10:30 AM

10:30 AM - 11:00 AM

  • Interviewee: Dr. Laura Mauri
  • Topic: Risk and Benefit of Prolonged Dual Antiplatelet Therapy After Drug-eluting Coronary Stents: Primary Endpoint Results from the Dual Antiplatelet Therapy Study
  • Embargo Lift: Sunday, November 16, 2014 at 4:15 PM

11:00 AM

11:00 AM - 11:30 AM

  • Interviewee: Dr. Westby Fisher
  • Topic: ABIM Maintenance of Certification program

11:30 AM

OPEN TIME SLOT

12:00 PM

OPEN TIME SLOT

12:30 PM

OPEN TIME SLOT

1:00 PM

OPEN TIME SLOT

1:30 PM

OPEN TIME SLOT

2:00 PM

OPEN TIME SLOT

2:30 PM

OPEN TIME SLOT

3:00 PM

OPEN TIME SLOT

3:30 PM

3:30 PM - 4:00 PM

  • Interviewee: Prof. Dr. Sigmund Silber
  • Topic: AHA 2014 Wrap-Up in German

4:00 PM

OPEN TIME SLOT

4:30 PM

OPEN TIME SLOT